8-K 1 e600027_8k-healthaxis.htm CURRENT REPORT Untitled Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

     Date of report (Date of earliest event reported): January 9, 2006

Healthaxis Inc.

(Exact Name of Registrant as Specified in Its Charter)

Pennsylvania

(State or Other Jurisdiction of Incorporation)

0-13591   23-2214195

(Commission File Number)   (IRS Employer Identification No.)

7301 North State Highway 161, Suite 300, Irving, Texas   75039

(Address of Principal Executive Offices)   (Zip Code)

(972) 443-5000

(Registrant’s Telephone Number, Including Area Code)

     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

     On January 9, 2006, Aneesh P. Chopra resigned from the Board of Directors of Healthaxis Inc. (the “Company”) effective immediately. Mr. Chopra indicated that he has no disagreement with the Company on any matter, but is resigning as a result of his appointment to a senior level cabinet position in the State Government of Virginia.

     


 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: January 11, 2006

  HEALTHAXIS INC.
   

  By:    /s/ John M. Carradine
    
    John M. Carradine
    Chief Executive Officer